Results 101 to 110 of about 5,087,575 (343)
We investigated the toxicity of 12 active compounds commonly found in herbal weight loss supplements (WLS) using human liver and colon cell models. Epigallocatechin‐3‐gallate was the only compound showing significant toxicity. Metabolic profiling revealed protein degradation, disrupted energy and lipid metabolism suggesting that the inclusion of EGCG ...
Emily C. Davies +3 more
wiley +1 more source
Cardiovascular Disease Training Programmes: Three Schemes to Train Leaders for Future Challenges
Cardiovascular disease (CVD) represents the largest burden of disease globally and despite the availability of strong evidence supporting cost-effective treatments for people with CVD, the implementation of these treatments remains low, especially in low-
Amitava Banerjee +6 more
doaj +1 more source
Background: Ankle–Brachial Index (ABI) has a proven role in the baseline assessment of the individuals who are at a risk of cardiovascular diseases. Sparse data are available regarding the association of cardiovascular risk factors in type 2 diabetes ...
Chivukula Sridhar +2 more
doaj +1 more source
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
F. Visseren +105 more
semanticscholar +1 more source
This review provides an overview of bio‐based polymer sources, their unique functional properties and their environmental impact, and addresses their role as sustainable alternatives. It discusses end‐of‐life options, including composting and anaerobic digestion for renewable energy.
Sabina Kolbl Repinc +8 more
wiley +1 more source
The Aging Blood: Cellular Origins, Circulating Drivers, and Therapeutic Potential
As a conduit linking all organs, the blood system both reflects and actively drives systemic aging. This review highlights how circulating pro‐aging and antiaging factors and age‐associated hematopoietic stem cell dysfunction contribute to immunosenescence and multi‐organ decline, positioning the hematopoietic system as a target for aging intervention.
Hanqing He, Jianwei Wang
wiley +1 more source
Yike Li,1,* Peng Li,2,* Qiang Tang,3,* Ting Jiao,4 Yanxiang Gao,5 Shuoyan An,5 Hao Jiang,3 Hui Cheng,6 Zixuan Yang,1 Jiahui Zhou,1 Yuxuan Sun,7 Yining Yang,6 Jingang Zheng1,5 1Department of Cardiology, China-Japan Friendship ...
Li Y +12 more
doaj
Effects of dalcetrapib in patients with a recent acute coronary syndrome [PDF]
In observational analyses, higher levels of high-density lipoprotein (HDL) cholesterol have been associated with a lower risk of coronary heart disease events.
Abt, Markus +18 more
core +2 more sources
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
Jinhui Wu, Penghui Yang, Jing Zhang, Zhuo Chen, Yi Wei, Ya Su, Qijian Yi Department of Cardiovascular Medicine, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory ...
Wu J +6 more
doaj

